-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Maintains Buy on Rapport Therapeutics, Raises Price Target to $82

Benzinga·10/21/2026 16:30:04
Jones Trading analyst Justin Walsh maintains Rapport Therapeutics (NASDAQ:RAPP) with a Buy and raises the price target from $50 to $82.